logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Second Sight Medical Products (EYES) is a medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The company is based in Sylmar, CA. Eight other companies are scheduled for the week of Nov. 17, 2014. The full IPO calendar is…
Read more...
A working knowledge of molecular biology is essential for a biotech investor, but it helps when someone with deep knowledge of science and medicine can bring understanding to the people who commit capital to growth ideas. George Zavoico of MLV & Co. has that advantage, having been a senior investigator…
Read more...
What do you get when you combine a top-ranked industry analyst with a retired lieutenant colonel from the U.S. Marine Corp.? You get Steve Brozak, who brings his one-of-a kind perspective on the intricacies of Ebola virus disease to this interview with The Life Sciences Report. His military background, combined…
Read more...
NeuroDerm, Ltd. (NDRM) is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system, or CNS, disorders through proprietary formulations based on existing drugs that are intended to make a significant difference in patients' lives. It is based in Rehovot, Israel. Nine other companies are scheduled for the week…
Read more...
PRA Health Sciences (PRAH) is one of the world's leading global contract research organizations (CROs) by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It is based in Raleigh, NC. Nine other new companies are scheduled for the week of Nov. 10, 2014. The full IPO…
Read more...
When the biotechnology market hit a speed bump in early 2014, every stock in the sector was jolted. Large-cap biotech and big pharma have largely recovered, but small- and micro-cap companies haven't yet entirely recouped the losses. The performance of Streetwise Reports' Biotechnology Watchlist to date reflects this trend: The…
Read more...
The Joint Corp. (JYNT) is a rapidly growing franchisor of chiropractic clinics that operates on a non-insurance, cash-based model. It is based in Scottsdale, AZ. Ten other companies are scheduled to IPO for the week of Nov. 3, 2014.  The full IPO calendar is available at IPOpremium. SEC Documents Manager,…
Read more...
Nevro ($NVRO) is a medical device company that has developed and commercialized an innovative neuromodulation platform for the treatment of chronic pain. It is based in Menlo Park, CA. Tenother companies are scheduled for the week of Nov. 3, 2014. The full IPO calendar is available at IPOpremium. SEC Documents…
Read more...
Jaguar Animal Health ($JAGX) is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals. It is based in San Francisco, CA. Ten other companies are scheduled for the week of Nov. 3, 2014. The full IPO calendar is available at IPOpremium. SEC…
Read more...
Institutional investors are, by and large, unable to own shares in companies with market valuations of less than $100 million, which means most sellside analysts don't write research on very small companies. The paradox: The micro-cap space is where investors can find the tenbaggers. That disconnect and its attendant irony…
Read more...
Last year, Japan rolled out the red carpet for cell therapy developers with new legislation designed to expedite development of regenerative medicine solutions for all manner of disease. In this interview with The Life Sciences Report, former regenerative medicine consultant R. Lee Buckler, now a vice president with RepliCel Life…
Read more...
EndoStim ($STIM) is a medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD. It is based in St. Louis, MO. Four other companies are scheduled for the week of Oct. 20, 2014.  The full IPO…
Read more...
Page 1 of 47

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.